December 16, 2019
Valam acquired the assets

of BioLx Inc.

Valam has recently acquired the assets of the company BioLx, Inc., a start up with innovative “Respiratory Protection” proprietary technology, including unique face masks and nasal filters. BioLx holds three (3) US patent applications.

Sept. 15, 2019
American Academy of Otolaryngology – September 15-18, 2019

Valam announced today that it will exhibit in the upcoming annual meeting of the American Academy of Otolaryngology (Booth no. 1434), that will take place on September 15 – 18, 2019, in New Orleans, LA.

August 27, 2019
Zelegent Acquires Valam’s MISH Technology Platform, Extending Product Pipeline into Obstructive Sleep Apnea Therapeutics
July 31, 2018
Valam signed a cross licensing agreement with an undisclosed party for its intellectual property for Laser Removal of Biofilm (Halitosis)
August 2016
Valam, Sinus surgery methods receives U.S. Patent
9,402,686.   Dual access sinus surgery methods
July 1, 2016
Ron Hadani joined Valam as President and CEO.
Valam Corp. today reported that Ron Hadani has been appointed President and Chief Executive Officer and will be leading the company as it enters its commercialization phase and prepares to change its business charter.
May 2014
Valam, Chronic Sinusitis treatment methods receives U.S. Patent
8,721,696 Selective treatments for chronic rhinosinusitis
March 2014
Valam’s, Two step biofilm treatment system receives U.S. Patent
8,679,103 Two step mammalian biofilm treatment processes and systems
February 2012
Valam, Optical therapy and devices receives U.S. Patent
8,109,981 Optical therapies and devices

Please join us for our next webinar.
For more information please contact us.